Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Option exercise +1,965 8,751.19
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Shares withheld for taxes −873 $319.43 $279K 7,878.19
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Option exercise +1,574 9,452.19
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Shares withheld for taxes −699 $319.43 $223K 8,753.19
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Grant or award · Restricted Stock Unit +10,330 10,330
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Option exercise · Restricted Stock Unit −1,104 2,211
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Option exercise · Restricted Stock Unit −1,965 1,453
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Other disposition · Restricted Stock Unit −1,453 0
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Option exercise · Restricted Stock Unit −1,574 6,716
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Other disposition · Restricted Stock Unit −1,188 5,528
2019-02-12 McKenzie Paul EVP Pharmaceutical Oper & Tech Option exercise +1,263 5,639.63
2019-02-12 McKenzie Paul EVP Pharmaceutical Oper & Tech Shares withheld for taxes −380 $319.43 $121K 5,259.63
2019-02-12 McKenzie Paul EVP Pharmaceutical Oper & Tech Option exercise +1,799 7,058.63
2019-02-12 McKenzie Paul EVP Pharmaceutical Oper & Tech Shares withheld for taxes −539 $319.43 $172K 6,519.63
2019-02-12 McKenzie Paul EVP Pharmaceutical Oper & Tech Option exercise · Restricted Stock Unit −1,263 2,527
2019-02-12 McKenzie Paul EVP Pharmaceutical Oper & Tech Option exercise · Restricted Stock Unit −1,799 7,671
2019-02-12 McKenzie Paul EVP Pharmaceutical Oper & Tech Other disposition · Restricted Stock Unit −1,357 6,314
2019-02-12 McKenzie Paul EVP Pharmaceutical Oper & Tech Grant or award · Restricted Stock Unit +10,960 10,960
2019-02-12 Kramer Robin VP, Chief Accounting Officer Grant or award · Restricted Stock Unit +860 860
2019-02-12 Karp Daniel EVP, Corporate Development Grant or award · Restricted Stock Unit +6,260 6,260

Page 52 of 61 · 1,204 trades